Correction: Akiyama et al. Comparison of the Risk of Pneumonia Between Fluticasone Furoate/Umeclidinium/Vilanterol and Multiple-Inhaler Triple Therapy in Patients with COPD Using Health Insurance Claims Data: Final Analysis of Post-Marketing Database Surveillance in Japan. J. Clin. Med. 2025, 14, 4697
Year: 2026
Type: erratum
Abstract: There was an error in the original publication [...].
Source: Journal of Clinical Medicine
DOI: 10.3390/jcm15135093
Authors: Shoko Akiyama, Kenji Oda, Hiroko Mizohata, Natsuki Sasakura, Kenichi Hashimoto, Hiroki Maruoka
Institution: GlaxoSmithKline (Japan)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,137
Funder: GlaxoSmithKline Australia
Award: G8382254178
OpenAlex ID: W7166718228